How Long Does an IPO Take? Timeline Generator
Going public isn't one event — it's a chain of dependent phases, and the phase most founders underbudget is the SEC or FINRA review sitting in the middle. Pick a listing path to see the typical month-by-month critical path, or set a target listing date to back into when you actually need to kick off.
Build your critical path
Enter a target listing month above to back-compute a start-by date.
How this is modeled
Educational estimate only, not a quote, application, or legal opinion. Actual timing depends on your auditor, counsel, underwriter, or sponsoring broker-dealer, and on SEC or FINRA queue depth at the time you file — treat every range here as a planning input, not a promise.
What actually stretches an IPO timeline
The ranges above are typical, not guaranteed — here's where real timelines blow through the high end.
SEC comment cycles are the single biggest swing factor on an S-1. The SEC's Division of Corporation Finance typically returns a first round of comments 30 days after filing, and each subsequent round can add another 2–4 weeks once counsel drafts responses and the company amends the registration statement. Two rounds is common for a clean filer; three or more is common for a first-time issuer with an unusual capital structure, a related-party transaction that needs more disclosure, or financial statements that don't tie cleanly to the MD&A narrative. A single extra comment round can turn a 7-month S-1 into a 9-month one.
Audit restatements and PCAOB deficiency findings are the second-biggest swing factor, and they hit every path that requires audited financials. If the audit firm's PCAOB inspection history includes findings on similar engagements, or if the company's books require adjustment for revenue recognition, stock compensation, or related-party treatment, the audit itself can run months longer than budgeted — and it happens before the S-1 or Form 1-A is even filed, so it doesn't show up as a visible delay until the drafting phase stalls waiting on final numbers.
Deficiency letters are the reverse-merger and uplisting equivalent of SEC comments. FINRA's review of a Form 211 submission routinely generates one or more deficiency letters asking the sponsoring market maker for more information on the issuer's business, management, or share issuance history — each round adds 1–3 weeks, and a submission with real information gaps can stretch the "typical" 4–8 week window to 3–6 months. On the Nasdaq uplisting side, deficiency findings during the application review (usually around governance documentation, related-party disclosure, or the round-lot holder count after a reverse split) work the same way.
Calendar effects are underrated. Comment letter turnaround slows meaningfully around year-end and over the summer as SEC staff availability shifts, and underwriters are reluctant to price a deal the week before a major holiday or during a broad market drawdown — a roadshow that's "ready" in early December often doesn't price until mid-January. Build a buffer around known blackout windows rather than assuming every month behaves like every other month.
How this is modeled
Every path total is anchored to a sourced GPT.timelines figure; the phase split inside each total is a disclosed, non-regulatory modeling assumption.
The S-1 IPO total reads directly from GPT.timelines.s1Ipo (6–12 months) and splits into five sequential phases — audit and readiness prep, S-1 drafting, SEC review cycles, roadshow, and pricing — sized so the phase sums match the sourced total exactly at both ends of the range. The Reg A+ path anchors its middle phase to GPT.regA.qualificationMonths (4–6 months from first submission), with the median ~78-day qualification figure shown as a faster-than-typical benchmark once a filing is actually in front of the SEC; the prep and raise-period phases on either side are modeled ranges, not pulled from a regulatory schedule, because Reg A+ prep time and how long a raise stays open both vary by issuer and demand. The reverse merger path anchors its final phase to GPT.form211.reviewWeeks (4–8 weeks, converted to whole months for the chart) and sums the four phases to match GPT.timelines.reverseMerger (3–6 months) exactly. The uplisting path splits the single-number GPT.timelines.uplistingLeadTime (12 months) into four fixed readiness phases rather than a range, since it's published as a recommended runway, not a range.
The phase bars are drawn as a critical path: each bar's width and position are proportional to that phase's midpoint duration against the sum of all phase midpoints, assuming phases run one after another with no material overlap. In practice, some phases genuinely overlap — audit work often continues into the S-1 drafting phase, and roadshow prep starts before the last SEC comment round closes — so treat the bar chart as a planning sequence, not a strict non-overlapping schedule.
Worked example: a Delaware C-corp with $12M in trailing revenue and an audit already substantially complete targets a Nasdaq Capital Market listing via S-1. Readiness prep (finalizing PCAOB audit adjustments, seating an audit committee) runs 2.5 months since the audit is already in motion. Drafting the S-1 with counsel and the underwriter to first filing takes 1.5 months. The SEC issues two comment letter rounds at roughly 30 days each with company turnaround time, adding about 3 months. A 3-week roadshow and a 2-week pricing-and-closing window close it out. Total: roughly 8 months from kickoff to first trade — inside the 6–12 month range this tool models, and closer to the lean end specifically because the audit didn't start from zero.
Choosing your path: timeline vs. cost vs. control
The fastest path and the cheapest path are rarely the same path — a structural read before you commit to one.
| Path | Typical timeline | What you get | Where it slips |
|---|---|---|---|
| S-1 IPO | 6–12 months | New capital raised concurrently with listing; underwriter-marketed offering | SEC comment cycles; audit findings |
| Reg A+ Tier 2 | 9–19 months (prep + qualification + raise) | Retail-eligible raise up to $75M; lighter ongoing reporting than a full S-1 | Qualification review; how long the raise itself stays open |
| Reverse merger + Form 211 | 3–6 months | Fastest route to a reporting public company; no new capital raised in the process itself | Form 211 deficiency letters; "public but not trading" gap |
| OTC-to-Nasdaq uplisting | ~12-month runway | Moves an already-trading company onto a national exchange | Bid-price seasoning; round-lot holder count after a reverse split |
Frequently asked
What this tool assumes, and where real timelines diverge from the modeled range.
How long does a traditional S-1 IPO actually take?
Typically 6–12 months from kickoff to first trade, per the sourced range this tool uses. The low end assumes audited financials are largely ready going in and the SEC issues one or two comment rounds; the high end assumes the audit needs meaningful work and the filing goes through three or more comment rounds. Few companies land exactly at either extreme — most fall in the middle once the roadshow and pricing phases are added.
Is Reg A+ actually faster than a traditional S-1 IPO?
The SEC qualification step itself can be faster — the median is around 78 days once a Form 1-A is actually in front of the staff, versus the multi-round comment process common on an S-1. But qualification is only the middle third of a Reg A+ path: prep work before filing and the raise period after qualification both add real time, and a Reg A+ raise with soft investor demand can run longer than a well-marketed S-1. This tool models all three phases together, not just the qualification window, which is why the Reg A+ total range is wider than the S-1 range.
What does "public but not trading" mean in a reverse merger?
After a merger closes and the resulting company files its Super 8-K, the entity is a public, SEC-reporting company — but its shares still can't legally trade until a sponsoring FINRA-member broker-dealer files Form 211 and FINRA clears it for quotation. That gap, typically 4–8 weeks but sometimes 3–6 months with deficiency letters, is the single most misunderstood part of the reverse-merger path: "we closed the merger" and "our stock is trading" are two different milestones separated by a review process the issuer itself can't file for or directly control.
Why do SEC comment letters blow up my timeline more than anything else?
Because each round is sequential, not parallel — the company can't submit a second amendment until it has fully responded to the first round of comments, and the SEC's own review clock resets on every amendment. A filer with a clean, well-drafted S-1 and an audit with no open items can clear review in two rounds; a filer with a related-party transaction, an unusual revenue recognition policy, or a first-time auditor relationship should budget for three or more, which is the difference between the low and high end of the modeled 2–5 month SEC review phase.
How much lead time should I budget before applying to uplist to Nasdaq?
Twelve months is the commonly recommended runway, covering bid-price seasoning (Nasdaq generally wants the minimum bid sustained for a meaningful stretch of trading days, not just briefly touched), governance buildout (an independent audit committee, internal controls sufficient to support the listing standard chosen), sponsor engagement, and the application review itself. Companies that compress this by relying solely on a last-minute reverse split to hit the bid price without addressing round-lot holder count or governance gaps are the ones that see their applications bounce back with deficiency findings.
How reliable is the "start by" date this tool gives me?
It's a planning input, not a commitment. The calculation takes your target listing month and subtracts the high end of the selected path's modeled range, which is deliberately conservative — it assumes things go about as slowly as the sourced range allows, not the median case. Use it to sanity-check whether a target date is realistic at all; don't treat the specific month it returns as a date your underwriter, auditor, or FINRA sponsor is bound to hit.